Schapel GJ[au] - Search Results

Year	Number of Results
1971	1
1972	1
1973	1
1974	2
1975	3
1980	4
1981	3
1984	2
1986	1
1988	1
1989	1
1992	2
1993	1
1995	1
1996	1
1997	1
2005	1
2024	0

1

Schapel GJ. Schapel GJ. Med J Aust. 1984 Nov 24;141(11):765-6. doi: 10.5694/j.1326-5377.1984.tb113259.x. Med J Aust. 1984. PMID: 6239085 No abstract available.

2

Melatonin response in active epilepsy.

Schapel GJ, Beran RG, Kennaway DL, McLoughney J, Matthews CD. Schapel GJ, et al. Epilepsia. 1995 Jan;36(1):75-8. doi: 10.1111/j.1528-1157.1995.tb01669.x. Epilepsia. 1995. PMID: 8001514

3

Interaction between phenytoin and valproate.

Sansom LN, Beran RC, Schapel GJ. Sansom LN, et al. Among authors: schapel gj. Med J Aust. 1980 Aug 23;2(4):212. doi: 10.5694/j.1326-5377.1980.tb112200.x. Med J Aust. 1980. PMID: 6776391

4

Combination vigabatrin and lamotrigine therapy for intractable epilepsy.

Schapel GJ, Black AB, Lam EL, Robinson M, Dollman WB. Schapel GJ, et al. Seizure. 1996 Mar;5(1):51-6. doi: 10.1016/s1059-1311(96)80063-x. Seizure. 1996. PMID: 8777553 Free article. Clinical Trial.

5

Individualized patient assessment in the treatment of epilepsy with sodium valproate.

Beran RG, Read T, Reid M, Rischbieth RH, Sansom L, Schapel GJ, Stanley PE. Beran RG, et al. Among authors: schapel gj. Epilepsia. 1980 Aug;21(4):379-86. doi: 10.1111/j.1528-1157.1980.tb04085.x. Epilepsia. 1980. PMID: 6772435 Clinical Trial.

6

Pharmacokinetics of sodium valproate in epileptic patients: prediction of maintenance dosage by single-dose study.

Schapel GJ, Beran RG, Doecke CJ, O'Reilly WJ, Reece PA, Rischbieth RH, Sansom LN, Stanley PE. Schapel GJ, et al. Eur J Clin Pharmacol. 1980 Jan;17(1):71-7. doi: 10.1007/BF00561679. Eur J Clin Pharmacol. 1980. PMID: 6768573 Clinical Trial. No abstract available.

7

Potassium-sparing effect of amiloride in a diuretic factorial study in man.

Schapel GJ, Edwards DG, Robinson J. Schapel GJ, et al. Clin Exp Pharmacol Physiol. 1975 Jul-Aug;2(4):277-87. doi: 10.1111/j.1440-1681.1975.tb01834.x. Clin Exp Pharmacol Physiol. 1975. PMID: 1097143 Clinical Trial.

8

Hyperammonaemia and hepatotoxicity during chronic valproate therapy: enhancement by combination with other antiepileptic drugs.

Ratnaike RN, Schapel GJ, Purdie G, Rischbieth RH, Hoffmann S. Ratnaike RN, et al. Among authors: schapel gj. Br J Clin Pharmacol. 1986 Jul;22(1):100-3. Br J Clin Pharmacol. 1986. PMID: 3091053 Free PMC article.

9

Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures.

Schapel GJ, Beran RG, Vajda FJ, Berkovic SF, Mashford ML, Dunagan FM, Yuen WC, Davies G. Schapel GJ, et al. J Neurol Neurosurg Psychiatry. 1993 May;56(5):448-53. doi: 10.1136/jnnp.56.5.448. J Neurol Neurosurg Psychiatry. 1993. PMID: 8505632 Free PMC article. Clinical Trial.

10

Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.

Beran RG, Berkovic SF, Black AB, Danta G, Hiersemenzel R, Schapel GJ, Vajda FJ. Beran RG, et al. Among authors: schapel gj. Epilepsy Res. 2005 Jan;63(1):1-9. doi: 10.1016/j.eplepsyres.2004.09.005. Epub 2005 Jan 6. Epilepsy Res. 2005. PMID: 15716083 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

27 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year